Toll Free: 1-888-928-9744

Surgical Mesh - Medical Devices Pipeline Assessment, 2017

Published: Aug 1, 2017 | Pages: 189 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Surgical Mesh - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Surgical Mesh - Medical Devices Pipeline Assessment, 2017" provides an overview of Surgical Mesh currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Surgical Mesh pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Surgical Mesh under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Surgical Mesh and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons To Buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Surgical Mesh under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
 Table of Contents
1 Table of Contents 2 1.1 List of Tables 6 1.2 List of Figures 8 2 Introduction 9 2.1 Surgical Mesh Overview 9 3 Products under Development 10 3.1 Surgical Mesh - Pipeline Products by Stage of Development 10 3.2 Surgical Mesh - Pipeline Products by Territory 11 3.3 Surgical Mesh - Pipeline Products by Regulatory Path 12 3.4 Surgical Mesh - Pipeline Products by Estimated Approval Date 13 3.5 Surgical Mesh - Ongoing Clinical Trials 14 4 Surgical Mesh - Pipeline Products under Development by Companies 15 4.1 Surgical Mesh Companies - Pipeline Products by Stage of Development 15 4.2 Surgical Mesh - Pipeline Products by Stage of Development 17 5 Surgical Mesh Companies and Product Overview 18 5.1 Acera Surgical, Inc. Company Overview 18 5.1.1 Acera Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18 5.2 Admedus Ltd Company Overview 19 5.2.1 Admedus Ltd Pipeline Products & Ongoing Clinical Trials Overview 19 5.3 Anika Therapeutics Inc Company Overview 20 5.3.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 20 5.4 Boston Scientific Corp Company Overview 21 5.4.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 21 5.5 Colorado Therapeutics, LLC Company Overview 22 5.5.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 22 5.6 CorMedix Inc Company Overview 23 5.6.1 CorMedix Inc Pipeline Products & Ongoing Clinical Trials Overview 23 5.7 DSM Biomedical BV Company Overview 24 5.7.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 24 5.8 Ethicon US LLC Company Overview 28 5.8.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 28 5.9 Fibralign Corporation Company Overview 30 5.9.1 Fibralign Corporation Pipeline Products & Ongoing Clinical Trials Overview 30 5.10 Harbor MedTech Inc Company Overview 33 5.10.1 Harbor MedTech Inc Pipeline Products & Ongoing Clinical Trials Overview 33 5.11 John Hopkins University Company Overview 36 5.11.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 36 5.12 Medisse BV (Inactive) Company Overview 37 5.12.1 Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 37 5.13 Medlinx Acacia Pte Ltd Company Overview 39 5.13.1 Medlinx Acacia Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 39 5.14 Medtronic plc Company Overview 40 5.14.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 40 5.15 Polyganics BV Company Overview 42 5.15.1 Polyganics BV Pipeline Products & Ongoing Clinical Trials Overview 42 5.16 PolyNovo Biomaterials Pty Ltd Company Overview 43 5.16.1 PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 43 5.17 Proxy Biomedical Ltd Company Overview 44 5.17.1 Proxy Biomedical Ltd Pipeline Products & Ongoing Clinical Trials Overview 44 5.18 Refine LLC Company Overview 45 5.18.1 Refine LLC Pipeline Products & Ongoing Clinical Trials Overview 45 5.19 Retectix, LLC Company Overview 46 5.19.1 Retectix, LLC Pipeline Products & Ongoing Clinical Trials Overview 46 5.20 Revivicor Inc Company Overview 47 5.20.1 Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview 47 5.21 Samyang Biopharmaceuticals Corp Company Overview 48 5.21.1 Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 48 5.22 Silver Bullet Therapeutics, Inc. Company Overview 49 5.22.1 Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49 5.23 Soft Tissue Regeneration Inc Company Overview 50 5.23.1 Soft Tissue Regeneration Inc Pipeline Products & Ongoing Clinical Trials Overview 50 5.24 Teleflex Inc Company Overview 51 5.24.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 51 5.25 Tepha Inc Company Overview 52 5.25.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview 52 5.26 The Electrospinning Company Ltd Company Overview 53 5.26.1 The Electrospinning Company Ltd Pipeline Products & Ongoing Clinical Trials Overview 53 5.27 University of Maryland Baltimore Company Overview 54 5.27.1 University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview 54 5.28 University of South Florida Company Overview 55 5.28.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 55 6 Surgical Mesh- Recent Developments 56 6.1 Jul 26, 2017: Anika Reports Strong Second Quarter 2017 Financial Results 56 6.2 Jul 25, 2017: Collagen Solutions: Transitioning to accelerated sustainable growth 57 6.3 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results 63 6.4 Jul 21, 2017: Endo to Restructure Manufacturing Network 65 6.5 Jul 13, 2017: MiMedx Announces that its Second Quarter Revenue Exceeds the Guidance Range 65 6.6 Jul 11, 2017: Collagen Solutions: Final Results for the year ended 31 March 2017 66 6.7 Jul 05, 2017: MiMedx Agreement With AvKARE Expires As Planned Following Completion Of Contract Wind-Down 66 6.8 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 67 6.9 Jun 09, 2017: Admedus Appoints David St. Denis as Chief Operating Officer 69 6.10 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 70 6.11 Jun 07, 2017: Endo Announces Entry of Significant Case Management Order in Mesh Multidistrict Litigation 70 6.12 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 71 6.13 May 25, 2017: BioLineRx Reports First Quarter 2017 Financial Results 74 6.14 May 15, 2017: Colorado Therapeutics Appoints Medtronic Executive John Lorbiecki as Chief Operating Officer in Advance of XI-S+ Launch 76 6.15 May 12, 2017: Integra LifeSciences launches SurgiMend MP Collagen Matrix for Hernia Repair 76 6.16 May 10, 2017: The Centers for Disease Control and Prevention Updated Guideline Now Include a Recommendation for Triclosan-Coated Sutures 77 6.17 May 09, 2017: Endo Reports First-Quarter 2017 Financial Results 77 6.18 May 03, 2017: Wright Medical Group Reports 2017 First Quarter Financial Results 80 6.19 May 03, 2017: Anika Reports First Quarter 2017 Financial Results 83 6.20 May 03, 2017: Coloplast delivers satisfactory Q2 result 84 6.21 Apr 28, 2017: MiMedx Announces Record Results For First Quarter Of 2017 84 6.22 Apr 27, 2017: Tepha Subsidiary, Galatea Surgical, Announces the Launch of GalaFORM 3D Surgical Scaffold 86 6.23 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 87 6.24 Apr 27, 2017: RTI Surgical Announces 2017 First Quarter Results 88 6.25 Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results 89 6.26 Apr 24, 2017: Proxy Biomedical Group Announces New Corporate Brand Aran Biomedical 90 6.27 Apr 24, 2017: Collagen Solutions: Consolidation of US R&D activities and Board change 91 6.28 Apr 23, 2017: Bard Announces First Quarter Results 91 6.29 Apr 20, 2017: Long-term study shows continuous improvement of quality of life following cystocele repair with alloplastic mesh implant 92 6.30 Apr 18, 2017: RTI Surgical Expands Line of Matrices in International Markets 93 6.31 Apr 13, 2017: MiMedx Announces First Quarter 2017 Revenue to Exceed High End of Guidance 94 6.32 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 95 6.33 Mar 31, 2017: B. Braun continues its sales and earnings growth 95 6.34 Mar 29, 2017: Tepha Subsidiary, Galatea Surgical, Announces Launch of GalaSHAPE 3D Surgical Scaffold 97 6.35 Mar 23, 2017: BioLineRx Reports Year End 2016 Financial Results 98 6.36 Mar 20, 2017: Collagen Solutions introduces new online sales initiative in the US 100 6.37 Mar 19, 2017: MiMedx Announces The Addition Of Luis A. Aguilar To Its Board Of Directors 100 6.38 Mar 15, 2017: Admedus Appoints Wayne Paterson As Chief Executive Officer 101 6.39 Mar 14, 2017: Admedus Appoints John Seaberg As Chairman 103 6.40 Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech 103 6.41 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 104 6.42 Feb 28, 2017: Endo Reports Fourth-Quarter And Full-Year 2016 Financial Results 105 6.43 Feb 24, 2017: Admedus Announces Half Yearly Report 108 6.44 Feb 23, 2017: RTI Surgical Announces 2016 Fourth Quarter, Full Year Results; Initiates Actions to Improve Execution and Return to Profitable Growth 110 6.45 Feb 23, 2017: MiMedx Announces 2016 Record Results 112 6.46 Feb 22, 2017: Change in the B. Braun Management Board 114 6.47 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 114 6.48 Feb 21, 2017: Wright Medical Group Reports 2016 Fourth Quarter and Full-Year Financial Results and Provides 2017 Guidance 117 6.49 Feb 20, 2017: ACERA Selected as One of the “Best University Startups 2016” by National Council of Entrepreneurial Tech Transfer 119 6.50 Feb 15, 2017: CryoLife Reports Fourth Quarter and Full Year 2016 Financial Results 120 6.51 Feb 15, 2017: Anika Reports Fourth Quarter and Full Year 2016 Financial Results 120 6.52 Feb 15, 2017: Anika Therapeutics Reports 33% Revenue Growth in Third Quarter 2011 121 6.53 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 123 6.54 Feb 02, 2017: Coloplast delivers Satisfactory Q1 Interim Results in Line with Guidance 123 6.55 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 124 6.56 Jan 26, 2017: Bard Announces Fourth Quarter Results 125 6.57 Jan 26, 2017: Endo Announces Actions to Drive Greater Efficiency and Business Alignment 126 6.58 Jan 26, 2017: RTI Surgical Names Camille Farhat Chief Executive Officer 127 6.59 Jan 19, 2017: Collagen Solutions Team Strengthened with New Scientific Advisory Board Appointments 128 6.60 Jan 17, 2017: RTI Surgical Extends Deadline for Nominating Directors to the Board 128 6.61 Jan 09, 2017: MiMedx Fourth Quarter 2016 Revenue in Upper Range of Guidance 129 6.62 Dec 23, 2016: Admedus Finishes Year With Growing Revenue After Completing Code Red Review 130 6.63 Dec 21, 2016: Endo Announces Appointments and Updates to Executive Management Team 131 6.64 Dec 20, 2016: FDA Approval for Endoform Plastics and Reconstructive Matrix 132 6.65 Dec 20, 2016: Endo Announces Appointment of Blaise Coleman as Chief Financial Officer 133 6.66 Dec 19, 2016: Collagen Solutions Announces Interim Results for the six months ended 30 September 2016 133 6.67 Dec 16, 2016: MiMedx 2017 Guidance Forecasts Revenue Growth In Excess Of 21% And Operating Earnings Growth In Excess Of 90% 134 6.68 Dec 15, 2016: W. L. Gore & Associates Receives Innovative Technology Designation from Vizient for GORE SYNECOR Biomaterial 135 6.69 Dec 14, 2016: RTI Surgical Names Robert P. Jordheim Interim CEO 136 6.70 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 136 6.71 Nov 22, 2016: BioLineRx Reports Third Quarter 2016 Financial Results 139 6.72 Nov 21, 2016: TELA Bio Announces Settlement of Litigation with LifeCell 141 6.73 Nov 16, 2016: Tepha Subsidiary, Galatea Surgical, Announces Presentation of GalaFLEX Surgical Scaffold Clinical Data at London Breast Meeting 142 6.74 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 142 6.75 Nov 08, 2016: Endo Reports Third Quarter 2016 Financial Results 143 6.76 Nov 07, 2016: Endo Strengthens Leadership Team with Appointment of Two Key Executives 144 6.77 Nov 03, 2016: DSM Q3 2016 Results 145 6.78 Nov 03, 2016: MiMedx Announces USP-NF Monograph For dHACM Allografts Has Published 147 6.79 Nov 02, 2016: Wright Medical Group Reports 2016 Third Quarter Financial Results and Updates 2016 Guidance 148 6.80 Nov 02, 2016: Coloplast delivers full-year results in line with guidance 150 6.81 Oct 27, 2016: MiMedx Announces Third Quarter 2016 Results 151 6.82 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 154 6.83 Oct 26, 2016: CryoLife Reports Third Quarter 2016 Financial Results 156 6.84 Oct 26, 2016: Anika Reports Third Quarter 2016 Financial Results 157 6.85 Oct 25, 2016: RTI Surgical Announces 2016 Third Quarter Results 157 6.86 Oct 25, 2016: James W. Bullock Joins CryoLife Board of Directors 159 6.87 Oct 25, 2016: Bard Announces Third Quarter Results 159 6.88 Oct 21, 2016: Colorado Therapeutics Receives 510(k) Clearance for a Novel Xenograft Implant for Soft Tissue Repairs 160 6.89 Oct 20, 2016: Endo Announces Departure of Chief Financial Officer 160 6.90 Oct 10, 2016: Long-term cystocele repair and improved quality of life 161 6.91 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 162 6.92 Oct 10, 2016: MiMedx Third Quarter 2016 Revenue Exceeds Upper End of Guidance 163 6.93 Sep 30, 2016: Hernia Mesh Lawsuit Filed on Behalf of Ethicon Physiomesh Patient Scheduled for January 2018 Trial, Bernstein Liebhard Reports 164 6.94 Sep 27, 2016: Orange County Business Council Study Showcases Economic Impact of Allergan on California Economy 165 6.95 Sep 25, 2016: Admedus Strengthens Management Team 166 6.96 Sep 23, 2016: Endo Names Paul Campanelli President and Chief Executive Officer 166 6.97 Sep 19, 2016: Organogenesis Announces New Chief Financial Officer 167 6.98 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 168 6.99 Sep 13, 2016: FDA Clears Omega3-rich Fish Skin for Surgical Applications 169 6.100 Sep 09, 2016: Admedus Announces Settlement Of Federal Court Proceedings 169 6.101 Sep 06, 2016: MiMedx Reaffirms Q3 and Full Year 2016 Guidance 170 6.102 Sep 06, 2016: CryoLife Appoints James McDermid as Chief Human Resources Officer 170 6.103 Sep 01, 2016: Fibralign Announces Enrollment Initiated for Stanford-Led Clinical Trial for Breast Cancer-Related Lymphedema 171 6.104 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 172 6.105 Aug 26, 2016: Admedus Appoints New Chief Financial Officer 172 6.106 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 173 6.107 Aug 18, 2016: Deceptive marketing of surgical transvaginal mesh leads to trouble for Johnson & Johnson 175 6.108 Aug 16, 2016: Coloplast delivers 9M result in line with guidance 176 6.109 Aug 15, 2016: RTI Surgical Announces CEO Brian Hutchison to Retire 177 6.110 Aug 11, 2016: BioLineRx Names Philip A. Serlin as Chief Executive Officer 177 6.111 Aug 11, 2016: BioLineRx Reports Second Quarter 2016 Financial Results 178 6.112 Aug 08, 2016: Endo Reports Second Quarter 2016 Financial Results 180 6.113 Aug 02, 2016: Wright Medical Group Reports 2016 Second Quarter Financial Results and Increases 2016 Guidance 182 7 Appendix 186 7.1 Methodology 186 7.2 About GlobalData 189 7.3 Contact Us 189 7.4 Disclaimer 189
List of Tables
Table 1: Surgical Mesh - Pipeline Products by Stage of Development 10 Table 2: Surgical Mesh - Pipeline Products by Territory 11 Table 3: Surgical Mesh - Pipeline Products by Regulatory Path 12 Table 4: Surgical Mesh - Pipeline Products by Estimated Approval Date 13 Table 5: Surgical Mesh - Ongoing Clinical Trials 14 Table 6: Surgical Mesh Companies - Pipeline Products by Stage of Development 15 Table 7: Surgical Mesh - Pipeline Products by Stage of Development 17 Table 8: Acera Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18 Table 9: Surgical Mesh - Orthopedic Surgery - Product Status 18 Table 10: Surgical Mesh - Orthopedic Surgery - Product Description 18 Table 11: Admedus Ltd Pipeline Products & Ongoing Clinical Trials Overview 19 Table 12: GyneCel - Product Status 19 Table 13: GyneCel - Product Description 19 Table 14: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 20 Table 15: HYAFF Mesh - Product Status 20 Table 16: HYAFF Mesh - Product Description 20 Table 17: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 21 Table 18: Next Generation Abdominal Mesh - Product Status 21 Table 19: Next Generation Abdominal Mesh - Product Description 21 Table 20: Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 22 Table 21: XI-S+ - Product Status 22 Table 22: XI-S+ - Product Description 22 Table 23: CorMedix Inc Pipeline Products & Ongoing Clinical Trials Overview 23 Table 24: Taurolidine Surgical Mesh - Product Status 23 Table 25: Taurolidine Surgical Mesh - Product Description 23 Table 26: DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 24 Table 27: Bioadhesive Surgical Mesh - Tendon Repair - Product Status 24 Table 28: Bioadhesive Surgical Mesh - Tendon Repair - Product Description 24 Table 29: Meso BioMatrix - Breast Surgery - Product Status 25 Table 30: Meso BioMatrix - Breast Surgery - Product Description 25 Table 31: DSM Biomedical BV - Ongoing Clinical Trials Overview 26 Table 32: Meso BioMatrix - Breast Surgery - Meso BioMatrix Acellular Peritoneum Matrix Breast Reconstruction Feasibility Trial 27 Table 33: Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 28 Table 34: GYNECARE Next Generation Pelvic Floor Repair Device - Product Status 28 Table 35: GYNECARE Next Generation Pelvic Floor Repair Device - Product Description 28 Table 36: GYNECARE PROLIFT Next Generation - Product Status 29 Table 37: GYNECARE PROLIFT Next Generation - Product Description 29 Table 38: Fibralign Corporation Pipeline Products & Ongoing Clinical Trials Overview 30 Table 39: BioBridge Collagen Matrix - Secondary Lymphedema - Product Status 30 Table 40: BioBridge Collagen Matrix - Secondary Lymphedema - Product Description 30 Table 41: Fibralign Corporation - Ongoing Clinical Trials Overview 31 Table 42: BioBridge Collagen Matrix - Secondary Lymphedema - Prospective Evaluation of the Biobridge Scaffold as an Adjunct to Vascularized Lymph Node Transfer for Upper Extremity Lymphedema 32 Table 43: Harbor MedTech Inc Pipeline Products & Ongoing Clinical Trials Overview 33 Table 44: EPMatrix - Breast Reconstruction - Product Status 33 Table 45: EPMatrix - Breast Reconstruction - Product Description 33 Table 46: Surgical Mesh - Joint Repair - Product Status 34 Table 47: Surgical Mesh - Joint Repair - Product Description 34 Table 48: Surgical Mesh - Urogynecological Repair - Product Status 34 Table 49: Surgical Mesh - Urogynecological Repair - Product Description 35 Table 50: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 36 Table 51: 3D Facial Reconstruction Pre-Form Mesh - Product Status 36 Table 52: 3D Facial Reconstruction Pre-Form Mesh - Product Description 36 Table 53: Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 37 Table 54: Composite Hernia Mesh - Product Status 37 Table 55: Composite Hernia Mesh - Product Description 37 Table 56: PTMC Prolapse - Product Status 38 Table 57: PTMC Prolapse - Product Description 38 Table 58: Medlinx Acacia Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 39 Table 59: PVDV Hernia Mesh - Product Status 39 Table 60: PVDV Hernia Mesh - Product Description 39 Table 61: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 40 Table 62: Hernia Repair Device - Product Status 40 Table 63: Hernia Repair Device - Product Description 40 Table 64: ProGrip Mesh - Product Status 41 Table 65: ProGrip Mesh - Product Description 41 Table 66: Polyganics BV Pipeline Products & Ongoing Clinical Trials Overview 42 Table 67: Surgical Mesh - Product Status 42 Table 68: Surgical Mesh - Product Description 42 Table 69: PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 43 Table 70: NovoFlex - Product Status 43 Table 71: NovoFlex - Product Description 43 Table 72: Proxy Biomedical Ltd Pipeline Products & Ongoing Clinical Trials Overview 44 Table 73: ExtreMESH - Product Status 44 Table 74: ExtreMESH - Product Description 44 Table 75: Refine LLC Pipeline Products & Ongoing Clinical Trials Overview 45 Table 76: Refine Support System - Product Status 45 Table 77: Refine Support System - Product Description 45 Table 78: Retectix, LLC Pipeline Products & Ongoing Clinical Trials Overview 46 Table 79: DuraStar Dural Substitue - Product Status 46 Table 80: DuraStar Dural Substitue - Product Description 46 Table 81: Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview 47 Table 82: Hernia Repair Scaffold - Product Status 47 Table 83: Hernia Repair Scaffold - Product Description 47 Table 84: Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 48 Table 85: Absorbable Surgical Mesh - Product Status 48 Table 86: Absorbable Surgical Mesh - Product Description 48 Table 87: Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49 Table 88: Galvanis Mesh - Product Status 49 Table 89: Galvanis Mesh - Product Description 49 Table 90: Soft Tissue Regeneration Inc Pipeline Products & Ongoing Clinical Trials Overview 50 Table 91: 3D Surgical Mesh - Breast Reconstruction - Product Status 50 Table 92: 3D Surgical Mesh - Breast Reconstruction - Product Description 50 Table 93: Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 51 Table 94: Double-Sided Hernia Mesh - Product Status 51 Table 95: Double-Sided Hernia Mesh - Product Description 51 Table 96: Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview 52 Table 97: TephaFLEX Absorbable Knitted Multifilament Mesh - Product Status 52 Table 98: TephaFLEX Absorbable Knitted Multifilament Mesh - Product Description 52 Table 99: The Electrospinning Company Ltd Pipeline Products & Ongoing Clinical Trials Overview 53 Table 100: Bio-Synthetic Surgical Mesh - Product Status 53 Table 101: Bio-Synthetic Surgical Mesh - Product Description 53 Table 102: University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview 54 Table 103: Hybrid Mesh - Product Status 54 Table 104: Hybrid Mesh - Product Description 54 Table 105: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 55 Table 106: SiC Nanoparticle Impregnated Surgical Mesh - Product Status 55 Table 107: SiC Nanoparticle Impregnated Surgical Mesh - Product Description 55 Table 108: Glossary 188


List of Figures
Figure 1: Surgical Mesh - Pipeline Products by Stage of Development 10 Figure 2: Surgical Mesh - Pipeline Products by Territory 11 Figure 3: Surgical Mesh - Pipeline Products by Regulatory Path 12 Figure 4: Surgical Mesh - Pipeline Products by Estimated Approval Date 13 Figure 5: Surgical Mesh - Ongoing Clinical Trials 14

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecast

Read More...

Global non destructive testing equipment market is anticipated to reach USD 5.76 billion by 2022, as per a new research report by Radiant Insights, Inc. Stringent government safety initiatives for inspection and quality control across numerous indust

Read More...

Global 3D scanning market is expected to be valued at USD 4,900.7 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing need for speedy and precise results with high efficiency is anticipated to drive the industry. 3D

Read More...

Global automotive collision repair market is expected to be valued at USD 196.97 billion by 2020, as per a new research report by Radiant Insights, Inc. The industry is expected to witness significant growth owing to increasing number of on-road vehi

Read More...

Global automotive electronics market size forecast is likely to reach USD 279.96 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing application scope of these equipments is estimated to drive industry growth. Increasing i

Read More...
Choose License Type
Single User - US $4000
Multi User - US $8000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify